From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications

The mainstay of moderate to severe Crohn's disease (CD), anti-TNF treatment, shows no clinical benefit in ∼40% of patients, likely due to incomplete cellular targeting and delayed treatment institution. While single-target therapeutics have been highly effective for some CD patients, substantia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shikha Nayar, Judy H. Cho
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
R
Acceso en línea:https://doaj.org/article/2edd0d56275e427b91380fd2fdfcbd3a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!